NTN1 and Parkinson disease: A recent study reveals a significant decrease in plasma Netrin-1 levels with a positive correlation with UPDRS (Unified Parkinson’s Disease Rating Scale) scores in PD patients (Hua et al., 2023), strongly supporting its biomarker potential in this second most common neurodegenerative disease.